|
|
|
|
 Dr Grace Wong,
CEO ActoKine Therapeutics, United States Grace has spent her entire career on biologics, specifically on cytokines, at Genentech, Millennium, AstraZeneca and Serono. Her PhD project was on biologics at The Walter and Eliza Hall Institute of Medical Research, Australia. Her post-doc projects were also on biologics with Dr. David Goeddel at Genentech. She continued working on biologics in a variety of diseases at Genentech, Millennium, AstraZeneca and Serono. Grace successfully shepherded basic research discoveries to product development at Genentech in 1993 and was appointed Head of Apoptosis Research at Millennium in 1996 for discovery of drug resistance genes using functional genomics. Grace joined AstraZeneca as Section Head of Molecular Genetics for discovery of cytokine inducible genes in Alzheimer’s disease. At Serono, Grace was Director of Cytokine Genomics for discovery of novel cytokines in Women’s diseases.
Her work with biologics have made her valuable to biotech and pharma, receiving also job offers from Glaxo, Biogen, Human Genome Sciences and Cell Therapeutics, in addition to the positions she was able to accept. Grace has been invited to present at 167 international conferences including the Nobel Symposium in Sweden. Grace received 13 scholarships and 5 Recognition Awards from Genentech. She published 95 papers and 29 patents. Some of her publications (3 Nature, 1 Science, 3 Cell, 5 PNAS and 7 J. Immunol) have received > 300-1000 citations. Grace founded ActoKine Therapeutics to discover new biologics for radioprotection and prevention of a board spectrum of viral infection (www.actokine.com). Grace also founded Student Vision (www.studentvision.org) and Nobel-Pauling (www.pauling.us) to inspire students of all ages in biotechnology.
Appearing: Conference Day One: Wednesday, 17 March 2010 11.00 Chairman’s opening remarks Dr Grace Wong, CEO,
ActoKine Therapeutics, United States 11.05 Utilize biomarkers in target identification in oncology and viral diseases Dr Grace Wong, CEO,
ActoKine Therapeutics, United States |
|
|
|
|
|
Session sponsor:
Exhibitors:
|
asia research institution poster presentation
* For first 20 confirmed poster presentations
|
|
|
|
|
|
|
|
|
